1-ethyl-3-(3-dimethylaminoethyl)carbodiimide and Breast Cancer

1-ethyl-3-(3-dimethylaminoethyl)carbodiimide has been researched along with Breast Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Li, S; Parrish, RS; Pumphrey, CY; Sanderson, RD; Theus, AM	1

Other Studies

1 other study(ies) available for 1-ethyl-3-(3-dimethylaminoethyl)carbodiimide and Breast Cancer

Article	Year
Neoglycans, carbodiimide-modified glycosaminoglycans: a new class of anticancer agents that inhibit cancer cell proliferation and induce apoptosis. Cancer research, 2002, Jul-01, Volume: 62, Issue:13 Topics: 3T3 Cells; Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carbodiimides; Cell Division; Cell Survival; CHO Cells; Chondroitin Sulfates; Cricetinae; Dogs; Drug Screening Assays, Antitumor; Female; Glycosaminoglycans; Heparin; Humans; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Multiple Myeloma; Proteoglycans; Syndecan-1; Syndecans; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2002

Article

Year

Neoglycans, carbodiimide-modified glycosaminoglycans: a new class of anticancer agents that inhibit cancer cell proliferation and induce apoptosis.

Cancer research, 2002, Jul-01, Volume: 62, Issue:13

Topics: 3T3 Cells; Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carbodiimides; Cell Division; Cell Survival; CHO Cells; Chondroitin Sulfates; Cricetinae; Dogs; Drug Screening Assays, Antitumor; Female; Glycosaminoglycans; Heparin; Humans; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Multiple Myeloma; Proteoglycans; Syndecan-1; Syndecans; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2002